Greene DA - Search Results

1

Feldman EL, Stevens MJ, Greene DA. Feldman EL, et al. Among authors: greene da. Clin Neurosci. 1997;4(6):365-70. Clin Neurosci. 1997. PMID: 9358981 Review.

2

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

Stevens MJ, Dananberg J, Feldman EL, Lattimer SA, Kamijo M, Thomas TP, Shindo H, Sima AA, Greene DA. Stevens MJ, et al. Among authors: greene da. J Clin Invest. 1994 Aug;94(2):853-9. doi: 10.1172/JCI117406. J Clin Invest. 1994. PMID: 8040341 Free PMC article.

3

Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.

Greene DA, Sima AA, Stevens MJ, Feldman EL, Killen PD, Henry DN, Thomas T, Dananberg J, Lattimer SA. Greene DA, et al. Diabetes Metab Rev. 1993 Oct;9(3):189-217. doi: 10.1002/dmr.5610090304. Diabetes Metab Rev. 1993. PMID: 8187607 Review. No abstract available.

4

Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.

Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA. Stevens MJ, et al. Among authors: greene da. Diabetologia. 1993 Jul;36(7):608-14. doi: 10.1007/BF00404069. Diabetologia. 1993. PMID: 8359577 Free article.

5

Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

Sima AA, Ristic H, Merry A, Kamijo M, Lattimer SA, Stevens MJ, Greene DA. Sima AA, et al. Among authors: greene da. J Clin Invest. 1996 Apr 15;97(8):1900-7. doi: 10.1172/JCI118621. J Clin Invest. 1996. PMID: 8621774 Free PMC article.

6

Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.

Stevens MJ, Lattimer SA, Feldman EL, Helton ED, Millington DS, Sima AA, Greene DA. Stevens MJ, et al. Among authors: greene da. Metabolism. 1996 Jul;45(7):865-72. doi: 10.1016/s0026-0495(96)90161-4. Metabolism. 1996. PMID: 8692023

7

Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy.

Greene DA, Stevens MJ, Obrosova I, Feldman EL. Greene DA, et al. Eur J Pharmacol. 1999 Jun 30;375(1-3):217-23. doi: 10.1016/s0014-2999(99)00356-8. Eur J Pharmacol. 1999. PMID: 10443578 Review.

8

Diabetic neuropathy: scope of the syndrome.

Greene DA, Stevens MJ, Feldman EL. Greene DA, et al. Am J Med. 1999 Aug 30;107(2B):2S-8S. doi: 10.1016/s0002-9343(99)00007-8. Am J Med. 1999. PMID: 10484039 Review. No abstract available.

9

Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Stevens MJ, et al. Among authors: greene da. Diabetes. 2000 Jun;49(6):1006-15. doi: 10.2337/diabetes.49.6.1006. Diabetes. 2000. PMID: 10866054

10

Complications: neuropathy, pathogenetic considerations.

Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA. Greene DA, et al. Diabetes Care. 1992 Dec;15(12):1902-25. doi: 10.2337/diacare.15.12.1902. Diabetes Care. 1992. PMID: 1464245 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters